187 related articles for article (PubMed ID: 17483353)
21. Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells.
Brito JL; Davies FE; Gonzalez D; Morgan GJ
J Immunol Methods; 2008 Apr; 333(1-2):147-55. PubMed ID: 18299137
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells.
Chen T; Deng C
Int Immunopharmacol; 2008 Jul; 8(7):1006-11. PubMed ID: 18486912
[TBL] [Abstract][Full Text] [Related]
23. Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.
Mook OR; Baas F; de Wissel MB; Fluiter K
Cancer Gene Ther; 2009 Jun; 16(6):532-8. PubMed ID: 19165236
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras.
Brunner TB; Cengel KA; Hahn SM; Wu J; Fraker DL; McKenna WG; Bernhard EJ
Cancer Res; 2005 Sep; 65(18):8433-41. PubMed ID: 16166322
[TBL] [Abstract][Full Text] [Related]
25. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous knockdown of p18INK4C, p27Kip1 and MAD1 via RNA interference results in the expansion of long-term culture-initiating cells of murine bone marrow cells in vitro.
Wang YY; Yang Y; Chen Q; Yu J; Hou Y; Han L; He J; Jiao D; Yu H
Acta Biochim Biophys Sin (Shanghai); 2008 Aug; 40(8):711-20. PubMed ID: 18685787
[TBL] [Abstract][Full Text] [Related]
27. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
28. RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase.
Scuto A; Zhang H; Zhao H; Rivera M; Yeatman TJ; Jove R; Torres-Roca JF
Cancer Res; 2007 Nov; 67(21):10317-24. PubMed ID: 17974974
[TBL] [Abstract][Full Text] [Related]
29. Ran suppresses paclitaxel-induced apoptosis in human glioblastoma cells.
Woo IS; Jang HS; Eun SY; Kim HJ; Ham SA; Kim HJ; Lee JH; Chang KC; Kim JH; Han CW; Seo HG
Apoptosis; 2008 Oct; 13(10):1223-31. PubMed ID: 18690538
[TBL] [Abstract][Full Text] [Related]
30. Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma.
Klosek SK; Nakashiro K; Hara S; Goda H; Hamakawa H
Oncol Rep; 2008 Oct; 20(4):873-8. PubMed ID: 18813829
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis.
Scaglia N; Igal RA
Int J Oncol; 2008 Oct; 33(4):839-50. PubMed ID: 18813799
[TBL] [Abstract][Full Text] [Related]
32. The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions.
Kappler M; Rot S; Taubert H; Greither T; Bartel F; Dellas K; Hänsgen G; Trott KR; Bache M
Cancer Gene Ther; 2007 Dec; 14(12):994-1001. PubMed ID: 17885676
[TBL] [Abstract][Full Text] [Related]
33. Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2.
Fang L; Hu Q; Hua Z; Li S; Dong W
Int J Oral Maxillofac Surg; 2008 Sep; 37(9):847-52. PubMed ID: 18620845
[TBL] [Abstract][Full Text] [Related]
34. Small interfering RNA against PTTG: a novel therapy for ovarian cancer.
El-Naggar SM; Malik MT; Kakar SS
Int J Oncol; 2007 Jul; 31(1):137-43. PubMed ID: 17549414
[TBL] [Abstract][Full Text] [Related]
35. Use of retrovirus expression of interfering RNA to determine the contribution of activated K-Ras and ras effector expression to human tumor cell growth.
Baines AT; Lim KH; Shields JM; Lambert JM; Counter CM; Der CJ; Cox AD
Methods Enzymol; 2006; 407():556-74. PubMed ID: 16757353
[TBL] [Abstract][Full Text] [Related]
36. TPX2 regulates tumor growth in human cervical carcinoma cells.
Jiang P; Shen K; Wang X; Song H; Yue Y; Liu T
Mol Med Rep; 2014 Jun; 9(6):2347-51. PubMed ID: 24718984
[TBL] [Abstract][Full Text] [Related]
37. The human trithorax protein hASH2 functions as an oncoprotein.
Lüscher-Firzlaff J; Gawlista I; Vervoorts J; Kapelle K; Braunschweig T; Walsemann G; Rodgarkia-Schamberger C; Schuchlautz H; Dreschers S; Kremmer E; Lilischkis R; Cerni C; Wellmann A; Lüscher B
Cancer Res; 2008 Feb; 68(3):749-58. PubMed ID: 18245475
[TBL] [Abstract][Full Text] [Related]
38. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.
Goda AE; Yoshida T; Horinaka M; Yasuda T; Shiraishi T; Wakada M; Sakai T
Oncogene; 2008 May; 27(24):3435-45. PubMed ID: 18193086
[TBL] [Abstract][Full Text] [Related]
40. A novel RNAi library based on partially randomized consensus sequences of nuclear receptors: identifying the receptors involved in amyloid beta degradation.
Yang JP; Fan W; Rogers C; Chatterton JE; Bliesath J; Liu G; Ke N; Wang CY; Rhoades K; Wong-Staal F; Li QX
Genomics; 2006 Sep; 88(3):282-92. PubMed ID: 16631344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
